1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Innate Pharma
  6. News
  7. Analyst Reco.
    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
Real-time Euronext Paris  -  07:52 2022-07-04 am EDT
2.714 EUR   -0.59%
06/23INNATE PHARMA : to Participate in Upcoming Investor Conference - Form 6-K
PU
06/21Top Premarket Gainers
MT
06/03SECTOR UPDATE : Health Care Stocks Flat To Lower Premarket Friday
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on INNATE PHARMA
2021ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...
2021INNATE PHARMA S A : SVB Leerink Upgrades Innate Pharma to Outperform from Market Perform
MT
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From Outperform..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50 From $13,..
MT
2020INNATE PHARMA S A : Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target
MT
2015France's 'economic patriotism' is not what it seems
RE
Upcoming event on INNATE PHARMA